Literature DB >> 9699646

Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.

E P Sulman1, J P Dumanski, P S White, H Zhao, J M Maris, T Mathiesen, C Bruder, A Cnaan, G M Brodeur.   

Abstract

Meningioma is a common tumor of the central nervous system. Deletions of the short arm of chromosome 1 (1p) are the second most commonly observed chromosomal abnormality in these tumors. Here, we analyzed tumor and normal DNAs from 157 meningioma patients using PCR-based polymorphic loci. Loss of heterozygosity (LOH) for at least one informative marker on 1p was observed in 54 cases (34%), whereas LOH on 1q occurred in only 9 cases (8%). High-resolution deletion mapping defined a consensus region of deletion flanked distally by D1S2713 and proximally by D1S2134, which spans 1.5 cM within 1p32. LOH in this region has also been observed in several other malignancies, suggesting the presence of a tumor suppressor gene or genes that are important for several types of cancer. Statistical analysis revealed that 1p LOH was associated with chromosome 22 deletions and with abnormalities of the NF2 gene in meningioma. In addition, unlike other clinical and molecular characteristics, only 1p LOH was shown to be significantly associated with recurrence-free survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699646

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.

Authors:  P Leuraud; Y Marie; E Robin; S Huguet; J He; K Mokhtari; P Cornu; K Hoang-Xuan; M Sanson
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 2.  Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Authors:  J Mora; N K Cheung; B H Kushner; M P LaQuaglia; K Kramer; M Fazzari; G Heller; L Chen; W L Gerald
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

3.  Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.

Authors:  Sayaka Yuzawa; Hiroshi Nishihara; Shigeru Yamaguchi; Hiromi Mohri; Lei Wang; Taichi Kimura; Masumi Tsuda; Mishie Tanino; Hiroyuki Kobayashi; Shunsuke Terasaka; Kiyohiro Houkin; Norihiro Sato; Shinya Tanaka
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

4.  Associations of meningioma molecular subgroup and tumor recurrence.

Authors:  Mark W Youngblood; Danielle F Miyagishima; Lan Jin; Trisha Gupte; Chang Li; Daniel Duran; Julio D Montejo; Amy Zhao; Amar Sheth; Evgeniya Tyrtova; Koray Özduman; Francesco Iacoangeli; Matthieu Peyre; Julien Boetto; Matthew Pease; Timuçin Avşar; Anita Huttner; Kaya Bilguvar; Türker Kilic; M Necmettin Pamir; Nduka Amankulor; Michel Kalamarides; E Zeynep Erson-Omay; Murat Günel; Jennifer Moliterno
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

5.  Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Authors:  J Boström; B Meyer-Puttlitz; M Wolter; B Blaschke; R G Weber; P Lichter; K Ichimura; V P Collins; G Reifenberger
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

Authors:  D G R Evans; C Watson; A King; A J Wallace; M E Baser
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

7.  Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.

Authors:  In Bok Chang; Byung Moon Cho; Seung Myung Moon; Se Hyuck Park; Sae Moon Oh; Seong Jin Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

8.  Tumor prognostic factors and the challenge of developing predictive factors.

Authors:  Emma B Holliday; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

9.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05

10.  Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.

Authors:  Darlene Gabeau-Lacet; David Engler; Sumeet Gupta; George A Scangas; Rebecca A Betensky; Fred G Barker; Jay S Loeffler; David N Louis; Gayatry Mohapatra
Journal:  J Neuropathol Exp Neurol       Date:  2009-10       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.